Standard BioTools Sells Microfluidics Business to ARCHIMED
PRIVATENov 03, 2026
Acquiring Company
ARCHIMED
FranceHealth CareVenture Capital
Description
On November 3, 2026, Standard BioTools Inc. announced the successful closing of the sale of its Microfluidics business to ARCHIMED. The transaction was part of a strategic move to focus on its core business areas. The partnership is expected to enhance ARCHIMED's portfolio in the healthcare sector.
Who to call at ARCHIMED, and when
When ARCHIMED changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
An alert the day ARCHIMED raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at ARCHIMED, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARCHIMED. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
ARCHIMED
Location
France
About
ARCHIMED is a leading investment firm that focuses exclusively on the healthcare industries. The firm is dedicated to supporting the growth and development of healthcare companies. With a deep understanding of the market, ARCHIMED aims to create value through strategic investments.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARCHIMED makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
FranceHealth CareVenture Capital